221 related articles for article (PubMed ID: 29327596)
1. Fertility preservation in BRCA-mutated women: when and how?
Grynberg M; Raad J; Comtet M; Vinolas C; Cédrin-Durnerin I; Sonigo C
Future Oncol; 2018 Feb; 14(5):483-490. PubMed ID: 29327596
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation in BRCA mutation carriers.
Revelli A; Salvagno F; Delle Piane L; Casano S; Evangelista F; Pittatore G; Razzano A; Marchino GL; Gennarelli G; Benedetto C
Minerva Ginecol; 2016 Oct; 68(5):587-601. PubMed ID: 26997146
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer.
Rodriguez-Wallberg KA; Oktay K
Oncologist; 2012; 17(11):1409-17. PubMed ID: 23006497
[TBL] [Abstract][Full Text] [Related]
6. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
[TBL] [Abstract][Full Text] [Related]
7. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
8. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
[TBL] [Abstract][Full Text] [Related]
9. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.
Oktay K; Kim JY; Barad D; Babayev SN
J Clin Oncol; 2010 Jan; 28(2):240-4. PubMed ID: 19996028
[TBL] [Abstract][Full Text] [Related]
10. [Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation?].
Sénéchal C; Rousset-Jablonski C
Gynecol Obstet Fertil; 2015 Dec; 43(12):800-5. PubMed ID: 26476890
[TBL] [Abstract][Full Text] [Related]
11. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
12. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
[TBL] [Abstract][Full Text] [Related]
13. Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.
Huber D; Seitz S; Kast K; Emons G; Ortmann O
Arch Gynecol Obstet; 2020 Sep; 302(3):715-720. PubMed ID: 32719921
[TBL] [Abstract][Full Text] [Related]
14. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
Nahshon C; Lavie O; Oron G
J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
[TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
16. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy.
Lambertini M; Ginsburg ES; Partridge AH
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):98-107. PubMed ID: 25490381
[TBL] [Abstract][Full Text] [Related]
17. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
[TBL] [Abstract][Full Text] [Related]
18. Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women.
de la Noval BD
Arch Gynecol Obstet; 2016 Nov; 294(5):1099-1103. PubMed ID: 27561295
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation and preimplantation genetic assessment for women with breast cancer.
Sciorio R; Anderson RA
Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734
[TBL] [Abstract][Full Text] [Related]
20. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Maehle L; Apold J; Paulsen T; Hagen B; Løvslett K; Fiane B; Van Ghelue M; Clark N; Møller P
Clin Cancer Res; 2008 Nov; 14(22):7569-73. PubMed ID: 19010876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
